The Next Frontier in Health Disparities-A Closer Look at Exploring Sex Differences in Glioma Data and Omics Analysis, from Bench to Bedside and Back.

in Biomolecules by Maria Diaz Rosario, Harpreet Kaur, Erdal Tasci, Uma Shankavaram, Mary Sproull, Ying Zhuge, Kevin Camphausen, Andra Krauze

TLDR

  • The study highlights the importance of considering sex differences in glioma research, as existing disparities may impact conclusions derived from large-scale data sets and omics analyses.

Abstract

Sex differences are increasingly being explored and reported in oncology, and glioma is no exception. As potentially meaningful sex differences are uncovered, existing gender-derived disparities mirror data generated in retrospective and prospective trials, real-world large-scale data sets, and bench work involving animals and cell lines. The resulting disparities at the data level are wide-ranging, potentially resulting in both adverse outcomes and failure to identify and exploit therapeutic benefits. We set out to analyze the literature on women's data disparities in glioma by exploring the origins of data in this area to understand the representation of women in study samples and omics analyses. Given the current emphasis on inclusive study design and research, we wanted to explore if sex bias continues to exist in present-day data sets and how sex differences in data may impact conclusions derived from large-scale data sets, omics, biospecimen analysis, novel interventions, and standard of care management.

Overview

  • The study aims to analyze the literature on women's data disparities in glioma to understand the representation of women in study samples and omics analyses.
  • The researchers explore the origins of data in this area to identify sex bias in present-day data sets and its potential impact on conclusions derived from large-scale data sets and omics analyses.
  • The primary objective is to investigate if sex differences in data may influence results and conclusions derived from omics, biospecimen analysis, novel interventions, and standard of care management.

Comparative Analysis & Findings

  • The study highlights the importance of considering sex differences in glioma research, as existing disparities mirror data generated in retrospective and prospective trials, real-world large-scale data sets, and bench work involving animals and cell lines.
  • The researchers found that sex bias in study design and data analysis may result in both adverse outcomes and the failure to identify and exploit therapeutic benefits, emphasizing the need for inclusive study design and research.
  • The study suggests that the representation of women in study samples and omics analyses may impact conclusions derived from large-scale data sets, omics, biospecimen analysis, novel interventions, and standard of care management, potentially leading to unintended consequences.

Implications and Future Directions

  • The study's findings emphasize the need for greater awareness and consideration of sex differences in glioma research, including the development of more inclusive study designs and research methodologies.
  • Future research should aim to understand the underlying causes of sex bias in study design and data analysis, as well as the potential impact of sex differences on therapeutic outcomes.
  • The study's results may inform the development of more targeted and effective therapies for glioma, particularly for women who are often underrepresented in biomedical research.
Read Full Article